NCT01845311View on ClinicalTrials.gov

ReZolve2 Clinical Investigation

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2019

Conditions
Coronary Artery DiseaseCoronary Artery Stenosis
Interventions
DEVICE

ReZolve2 Scaffold

Trial Locations (3)

Unknown

St Vincent's Hospital, Sydney

Instituto Dante Pazzanese de Cariologia, São Paulo

Cardioangiologisches Centrum Bethanien, Frankfurt

All Listed Sponsors
lead

REVA Medical, Inc.

INDUSTRY

NCT01845311 - ReZolve2 Clinical Investigation | Biotech Hunter | Biotech Hunter